Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Analysis of trends in GDP and Health Expenditure in OECD countries, with a focus on Health Insurance Roberto ASTOLFI and Luca LORENZONI Training Course on Social Health Insurance 2009 National Health Insurance Corporation Seoul, 17 June 2009 Background The System of Health Accounts proposes an integrated system of comprehensive and internationally comparable accounts and provides a uniform framework of basic accounting rules and a set of standard tables for reporting health expenditure data 2 Background (cont) The goal of the collaboration between OECD, EUROSTAT and WHO is to reduce the burden of data collection for the national authorities responsible for the provision of statistical information This joint effort also increases the use of international standards and definitions 3 Methods In 2005 the 3 organisations agreed to intensify their collaborative actions through a joint data collection based on: – a functional classification of health care (HC) – a classification of health care financing (HF) – a classification of health care providers (HP) – a classification of financing sources (FS) – a classification of resources (RC) 4 Methods (cont) Core tables (minimum requirement to countries): HC x HP: CHE by function of care and provider HC x HF: CHE by function of care and financing agent HP x HF: CHE by provider and financing agent CHE: Current Health Expenditure 5 Joint data collection 2009 Timing • 2009 JHAQ sent to health contacts on 15 December 2008 • Completed by 31 March 2009 by 27 countries • First validation by mid-May 2009 JHAQ: Joint Health Accounts Questionnaire 6 Joint data collection 2009 Preliminary results - Indicators • Health expenditure (HE) as a share of GDP –total; public; private • Current HE as a share of actual final consumption • Private HE components analysis • Population covered by private insurance 7 8 Preliminary results - one • OECD countries devoted for the fifth consecutive year about 8.9% of their GDP to health spending • The share of health spending varies considerably across OECD countries, ranging from less then 6% in Turkey and Mexico up to 16% in the United States • Also the share of public HE varies considerably across OECD countries – more than three-fold difference between France and Mexico 9 10 11 Preliminary results - two • Evidence of a positive association between GDP per capita and HE per capita across OECD countries • Association is stronger among OECD countries with a low GDP per capita • However, there is a wide variation since GDP is not the sole factor influencing HE levels 12 13 Preliminary results - three • The share of health goods and services to all goods and services consumed by individuals in the economy is more refined measure of relative importance of health spending • The average share of actual consumption allocated to health in OECD countries is almost 13%, with 90% of countries devoting more than 10% of consumption to health • Only Poland, Mexico, and Turkey are below the 10% threshold, while US, Switzerland, Luxembourg, and Norway above 15% 14 15 Preliminary results - four • The average share of private health expenditure to total health expenditure is stable over time for the OECD countries and equals 27-28% • In 2007, it ranges between 54% for United States and 9% for Luxembourg 16 Classification of sources of funding ICHA Sources of funding Code HF.1 General government HF.1.1 General government excluding social security funds HF.1.1.1 Central government HF.1.1.2 State/provincial government HF.1.1.3 Local/municipal government HF.1.2 Social security funds HF.2 Private sector HF.2.1 Private social insurance HF.2.2 Private insurance enterprises (other than social insurance) HF.2.3 Private household out-of-pocket expenditure HF.2.4 Non-profit organisations serving households (other than social insurance) HF.2.5 Corporations (other than health insurance) HF.3 Rest of the world 17 18 Preliminary results - five • Out-of-pocket expenditure is the most important component of private health expenditure (PHE) in almost all OECD member States • However, in the US, France, and the Netherlands the share of Private insurance expenditure to PHE is the highest • Non-profit institutions play an important role in UK and Turkey, while corporations are important in Australia and Slovak republic 19 Private health insurance coverage, by type 2007 Netherlands France (2006) Belgium Canada United States Luxembourg Ireland Australia Austria New Zealand Switzerland Germany Portugal Greece (2002) Denmark Spain (2006) United Kingdom (2006) Finland (2005) Mexico Turkey (2006) Iceland Primary Complementary Supplementary Duplicate Percentage of total population 0 10 20 30 40 50 60 70 80 20 90 100 Preliminary results - six • The share of population covered by Private Health Insurance (PHI) varies considerably across OECD countries. Seven countries report private coverage for over half of the population: Netherlands; France; Belgium; Canada; US; Luxembourg; and Ireland • PHI plays a diversity of role in the health system. Primary cover for certain population groups in the United States and Germany 21 Preliminary results - seven • It offers to 88% of the French population complementary insurance to cover cost sharing applied in the social security system • The Netherlands has largest supplementary market, followed by Canada whereby PHI pays for prescription drugs and dental care that are not publicly reimbursed • Duplicate markets providing faster private-sector access to medical services where there are waiting times in public systems are the largest 22 Thank you for your attention! For further information, please visit our websites: System of Health Accounts: www.oecd.org/health/sha Revison of the System of Health Accounts: www.oecd.org/health/sha/revision OECD-Eurostat-WHO Joint SHA Data Collection: www.oecd.org/health/sha/jointquestionnaire OECD Korea Policy Centre: www.oecdkorea.org 23